Correct binding of viral X protein to UVDDB-p127 cellular protein is critical for efficient infection by hepatitis B viruses
- 7 September 2000
- journal article
- Published by Springer Nature in Oncogene
- Vol. 19 (38) , 4427-4431
- https://doi.org/10.1038/sj.onc.1203770
Abstract
A fully effective treatment of chronic human hepatitis B virus (HBV) infection is still missing and HBV remains the first etiological agent of liver cancer. Although the viral regulatory X protein is essential for infection, its mode of action remains obscure, due the lack of an in vitro infection system. In the accompanying study, we showed the functional importance of interaction between X and the host protein UVDDB-p127, in the transactivation and apoptotic properties of the viral protein. Here, we addressed the biological role of X-UVDDB interaction in the infectious process using a genetic approach in the woodchuck virus closely related to HBV. We show that (i) mutations in X, which markedly affect UVDDB-binding, also abolished productive infection in woodchucks, (ii) in the few cases where mutant viruses led to infection, compensatory mutations had occurred in the X gene of the viral progeny, which restored correct UVDDB-binding. We conclude that efficient viral replication in vivo requires proper X-UVDDB interaction. The interaction may thus provide a novel therapeutic target for the treatment of hepatitisKeywords
This publication has 24 references indexed in Scilit:
- UVDDB p127-binding modulates activities and intracellular distribution of Hepatitis B virus X proteinOncogene, 2000
- The proapoptotic effect of hepatitis B virus HBx protein correlates with its transactivation activity in stably transfected cell linesOncogene, 1999
- Status of hepatitis B immunization programmes in 1998Vaccine, 1998
- The long‐term effect of treatment with interferon‐α2a in chronic hepatitis BJournal of Viral Hepatitis, 1998
- Hepatitis B virus HBx protein sensitizes cells to apoptotic killing by tumor necrosis factor αProceedings of the National Academy of Sciences, 1997
- The Mechanism of Action of Cyclosporin A and FK506Clinical Immunology and Immunopathology, 1996
- Hepatitis B virus replication-an updateJournal of Viral Hepatitis, 1996
- Hepatitis B virus X‐gene product: A promiscuous transcriptional activatorJournal of Medical Virology, 1992
- HEPATOCELLULAR CARCINOMA AND HEPATITIS B VIRUSThe Lancet, 1981
- Nucleotide sequence of the hepatitis B virus genome (subtype ayw) cloned in E. coliNature, 1979